HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,860.00
+30.00 (0.51%)
Jun 5, 2025, 3:30 PM KST

HLB Life Science Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
105,823102,24097,99099,59153,49491,797
Upgrade
Other Revenue
-0--00-0
Upgrade
Revenue
105,823102,24097,99099,59153,49491,797
Upgrade
Revenue Growth (YoY)
16.65%4.34%-1.61%86.17%-41.73%-19.49%
Upgrade
Cost of Revenue
108,821104,80998,915102,81359,15589,630
Upgrade
Gross Profit
-2,998-2,569-925.04-3,222-5,6612,167
Upgrade
Selling, General & Admin
14,27614,33715,22610,8398,2477,959
Upgrade
Research & Development
5,2465,1775,4544,3493,8461,431
Upgrade
Other Operating Expenses
368.88394.66279192.67113.46211.74
Upgrade
Operating Expenses
18,33318,47024,56816,72812,66810,184
Upgrade
Operating Income
-21,331-21,038-25,493-19,950-18,329-8,018
Upgrade
Interest Expense
-13,641-16,819-21,650-9,870-1,256-2,109
Upgrade
Interest & Investment Income
2,0001,8801,2881,203512.761,715
Upgrade
Earnings From Equity Investments
2,1181,354-2,5372,602--
Upgrade
Currency Exchange Gain (Loss)
-7.09121.23-93.2233.77-4.05111.25
Upgrade
Other Non Operating Income (Expenses)
-1,941119.02469.76-2,664-60.631,548
Upgrade
EBT Excluding Unusual Items
-32,802-34,383-48,015-28,646-19,137-6,752
Upgrade
Gain (Loss) on Sale of Investments
-142,46961,67081,336-20,548-21,296-27,533
Upgrade
Gain (Loss) on Sale of Assets
23.8423.84-304.963,157594.55313.04
Upgrade
Asset Writedown
-24,162-24,162-37,553-14,802-13,786-22,519
Upgrade
Other Unusual Items
---1,966---
Upgrade
Pretax Income
-199,4093,149-6,503-60,839-53,624-56,490
Upgrade
Income Tax Expense
-2,984-3,058-590.06-6,479-4,333-654.25
Upgrade
Earnings From Continuing Operations
-196,4266,207-5,913-54,360-49,292-55,836
Upgrade
Net Income to Company
-196,4266,207-5,913-54,360-49,292-55,836
Upgrade
Minority Interest in Earnings
328.07-68.89-70.3582.24139.8938.95
Upgrade
Net Income
-196,0986,138-5,983-54,277-49,152-55,797
Upgrade
Net Income to Common
-196,0986,138-5,983-54,277-49,152-55,797
Upgrade
Shares Outstanding (Basic)
1171131021019999
Upgrade
Shares Outstanding (Diluted)
1171131021019999
Upgrade
Shares Change (YoY)
14.51%10.73%0.80%1.64%0.34%6.39%
Upgrade
EPS (Basic)
-1675.0854.46-58.79-537.56-494.76-563.59
Upgrade
EPS (Diluted)
-1675.5254.00-59.00-537.56-494.76-563.85
Upgrade
Free Cash Flow
-65,655-59,301-30,634-40,420-16,505-6,400
Upgrade
Free Cash Flow Per Share
-560.83-526.20-300.99-400.32-166.14-64.64
Upgrade
Gross Margin
-2.83%-2.51%-0.94%-3.23%-10.58%2.36%
Upgrade
Operating Margin
-20.16%-20.58%-26.02%-20.03%-34.26%-8.73%
Upgrade
Profit Margin
-185.31%6.00%-6.11%-54.50%-91.88%-60.78%
Upgrade
Free Cash Flow Margin
-62.04%-58.00%-31.26%-40.59%-30.85%-6.97%
Upgrade
EBITDA
-16,050-15,138-17,797-14,727-15,845-5,763
Upgrade
EBITDA Margin
-15.17%-14.81%-18.16%-14.79%-29.62%-6.28%
Upgrade
D&A For EBITDA
5,2805,9017,6965,2232,4842,255
Upgrade
EBIT
-21,331-21,038-25,493-19,950-18,329-8,018
Upgrade
EBIT Margin
-20.16%-20.58%-26.02%-20.03%-34.26%-8.73%
Upgrade
Advertising Expenses
-96.93157.8669.1334.9241.38
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.